Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sheila A Doggrell. (2012) Dalcetrapib – restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease. Expert Opinion on Investigational Drugs 21:4, pages 569-573.
Read now
Read now
Alexander JM Rennings & Anton FH Stalenhoef. (2008) JTT-705: is there still future for a CETP inhibitor after torcetrapib?. Expert Opinion on Investigational Drugs 17:10, pages 1589-1597.
Read now
Read now
James A Sikorski. (2006) Cholesteryl ester transfer protein inhibitors as potential new therapies for coronary artery disease. Expert Opinion on Therapeutic Patents 16:6, pages 753-772.
Read now
Read now
Articles from other publishers (12)
Wen-Yan Li, Xu-Qiong Xiong, Dong-Mei Zhao, Yu-Fang Shi, Zhi-Heng Yang, Chao Yu, Pei-Wei Fan, Mao-Sheng Cheng & Jing-Kang Shen. (2012) Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors. Molecules 17:5, pages 5497-5507.
Crossref
Crossref
Ka Ying Ma, Nan Yang, Rui Jiao, Cheng Peng, Lei Guan, Yu Huang & Zhen‐Yu Chen. (2010) Dietary calcium decreases plasma cholesterol by down‐regulation of intestinal Niemann–Pick C1 like 1 and microsomal triacylglycerol transport protein and up‐regulation of CYP7A1 and ABCG 5/8 in hamsters. Molecular Nutrition & Food Research 55:2, pages 247-258.
Crossref
Crossref
Cheuk Kai Lam, Zesheng Zhang, Hongjian Yu, Suk-Ying Tsang, Yu Huang & Zhen Yu Chen. (2008) Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol. Molecular Nutrition & Food Research 52:8, pages 950-958.
Crossref
Crossref
R.L. Tiwari, V. Singh & M.K. Barthwal. (2007) Macrophages: An elusive yet emerging therapeutic target of atherosclerosis. Medicinal Research Reviews 28:4, pages 483-544.
Crossref
Crossref
Pitchai Balakumar, Tajpreet Kaur & Manjeet Singh. (2008) Potential target sites to modulate vascular endothelial dysfunction: Current perspectives and future directions. Toxicology 245:1-2, pages 49-64.
Crossref
Crossref
Ravi Kumar Trivedi, Pramod Kumar Dubey, Ramesh Mullangi & Nuggehally R. Srinivas. (2007) Development and validation of a sensitive LC‐MS/MS method with electrospray ionization using multiple ions for quantitation of torcetrapib in hamster and dog plasma. Biomedical Chromatography 22:3, pages 316-326.
Crossref
Crossref
Oliver Rau, Heiko Zettl, Laura Popescu, Dieter Steinhilber & Manfred Schubert-Zsilavecz. (2008) The Treatment of Dyslipidemia—What's Left in the Pipeline?. ChemMedChem 3:2, pages 206-221.
Crossref
Crossref
Ravi Kumar Trivedi, P.K. Dubey, Ramesh Mullangi & Nuggehally R. Srinivas. (2007) Development and validation of an enantioselective HPLC–UV method using Chiralpak AD-H to quantify (+)- and (−)-torcetrapib enantiomers in hamster plasma—application to a pharmacokinetic study. Journal of Chromatography B 857:2, pages 224-230.
Crossref
Crossref
Karim El Harchaoui, Wim A. van der Steeg, Erik S. G. Stroes & John J. P. Kastelein. (2007) The role of CETP inhibition in dyslipidemia. Current Atherosclerosis Reports 9:2, pages 125-133.
Crossref
Crossref
Oliver Rau, Heiko Zettl, Laura Nicoleta Popescu, Dieter Steinhilber & Manfred Schubert‐Zsilavecz. (2007)
Neue
Targets
und Wirkstoffe zur Behandlung von Fettstoffwechselstörungen: Arzneistoffe in der Pipeline
. Pharmazie in unserer Zeit 36:2, pages 142-148.
Crossref
Crossref
Dibyendu De & Ish Khanna. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42
177
191
.
Lila M Harada, Alexandre JF Carrilho, Helena CF Oliveira, Edna R Nakandakare & Eder CR Quintão. (2006)
REGULATION OF HEPATIC CHOLESTEROL METABOLISM IN CETP
+/?
/LDLr
+/?
MICE BY CHOLESTEROL FEEDING AND BY DRUGS (CHOLESTYRAMINE AND LOVASTATIN) THAT LOWER PLASMA CHOLESTEROL
. Clinical and Experimental Pharmacology and Physiology 33:12, pages 1209-1215.
Crossref
Crossref